Advances in Obesity Treatment

Editorial Board > Complete Profile


Katsunori Nonogaki

Designation : Post doctorate Research Fellow
University/Organisation : University of California
Qualification : M.D, Ph. D
Biography :  

Dr. Katsunori Nonogaki current studies are to determine the physiological mechanisms and potential treatment for obesity, type 2 diabetes and their complications. He has worked as a Post doctorate Research Fellow at the University of California, San Francisco and the Scripps Research Institute, La Jolla. He has studied central serotonin network in the regulation of appetite and energy homeostasis. Lorcaserin, a selective 5-HT2C receptor agonist, which is used for the treatment of obesity, is based on the original research works by Nonogaki et al. Nonogaki is also developing novel medical devices for hypertension and diabetes.